Diagnosis of Solid and Hematological Tumours in the Era of Artificial Intelligence (AI)
A special issue of Current Oncology (ISSN 1718-7729).
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 2502
Special Issue Editors
Interests: skin diseases; dermatology; dermatopathology; diagnosis
Special Issues, Collections and Topics in MDPI journals
Interests: e-health; artificial neural network; multilayer perceptron; smart health; homecare assistance management; telemedicine architecture; patient health status prediction; KNIME
Special Issue Information
Dear Colleagues,
In recent years the diagnosis of solid and hematological neoplasms has begun to be invested by a renewed enthusiasm and desire for research towards the use of technology in a field that is difficult in itself, such as human neoplasms. The spread of ever more powerful instruments has made it possible to transform large amounts of data into information flows that could be the basis for the development and training of Artificial Intelligence algorithms. In this Special Issue we are confronted on a very current terrain and we invite colleagues from different disciplines to present their contribution.
Dr. Gerardo Cazzato
Dr. Alessandro Massaro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence (AI)
- algorithm
- digital pathology
- digital oncology
- diagnosis
- neoplasms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
